Biohaven Ltd.
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Nov 17, 2026 (22 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Sep 10, 2026 | HC Wainwright & Co. | reiterate | Neutral → Neutral | — | 44% |
| Sep 8, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | — | 55% |
| Aug 12, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 11, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jun 29, 2026 | B of A Securities | downgrade | Neutral → Underperform | — | 53% |
| May 26, 2026 | HC Wainwright & Co. | reiterate | Neutral → Neutral | — | 44% |
| May 13, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 5, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Apr 2, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 11, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Mar 4, 2026 | HC Wainwright & Co. | maintain | Neutral → Neutral | — | 44% |
| Mar 3, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jan 21, 2026 | RBC Capital | upgrade | Sector Perform → Outperform | $22 | 55% |
| Jan 6, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $21 | 54% |
| Dec 26, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $11 | 44% |
| Dec 3, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $11 | 44% |
| Nov 26, 2025 | UBS | downgrade | Buy → Neutral | $11 | 54% |
| Nov 20, 2025 | JP Morgan | maintain | Overweight → Overweight | $15 | 55% |
| Nov 18, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $26 | 54% |
| Nov 18, 2025 | BTIG | reiterate | Buy → Buy | $16 | 52% |
| Nov 13, 2025 | Citigroup | maintain | Buy → Buy | $14 | 54% |
| Nov 6, 2025 | Bernstein | downgrade | Outperform → Market Perform | $9 | 52% |
| Nov 6, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $9 | 55% |
| Nov 6, 2025 | BTIG | maintain | Buy → Buy | $16 | 52% |
| Nov 5, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Nov 5, 2025 | TD Cowen | maintain | Buy → Buy | $15 | 54% |
| Sep 17, 2025 | Citigroup | initiate | — → Buy | $28 | 54% |
| Sep 16, 2025 | UBS | maintain | Buy → Buy | $26 | 54% |
| Sep 3, 2025 | Raymond James | initiate | — → Strong Buy | $75 | 54% |
| Aug 19, 2025 | BTIG | maintain | Buy → Buy | $60 | 52% |
| Aug 12, 2025 | Leerink Partners | maintain | Outperform → Outperform | $50 | 50% |
| Aug 12, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $54 | 54% |
| Aug 12, 2025 | B of A Securities | maintain | Buy → Buy | $49 | 53% |
| Aug 12, 2025 | Baird | maintain | Outperform → Outperform | $52 | 55% |
| Aug 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Jun 18, 2025 | JP Morgan | maintain | Overweight → Overweight | $55 | 55% |
| May 19, 2025 | RBC Capital | downgrade | Outperform → Sector Perform | $21 | 55% |
| May 13, 2025 | RBC Capital | maintain | Outperform → Outperform | $54 | 55% |
| Apr 28, 2025 | Baird | maintain | Outperform → Outperform | $57 | 55% |
| Mar 7, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $63 | 54% |
| Mar 5, 2025 | JP Morgan | maintain | Overweight → Overweight | $68 | 55% |
| Mar 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $54 | 44% |
| Mar 4, 2025 | RBC Capital | reiterate | Outperform → Outperform | $61 | 55% |
| Feb 11, 2025 | Deutsche Bank | initiate | — → Buy | $65 | 57% |
| Dec 17, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Dec 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $59 | 44% |
| Dec 4, 2024 | RBC Capital | reiterate | Outperform → Outperform | $61 | 55% |
| Nov 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $59 | 44% |
| Nov 25, 2024 | RBC Capital | maintain | Outperform → Outperform | $58 | 55% |
No cross-platform signals in the last 90 days